1988
DOI: 10.1111/j.1476-5381.1988.tb11408.x
|View full text |Cite
|
Sign up to set email alerts
|

Antinociceptive effects of the novel opioid peptide BW443C compared with classical opiates; peripheral versus central actions

Abstract: 1 To investigate peripherally mediated antinociceptive effects of opioids, the activity of a novel polar enkephalin analogue H-Tyr-D-Arg-Gly-Phe (4-NO2)-Pro-NH2 (BW443C) has been compared with those of classical tertiary opiates against different nociceptive stimuli in the mouse. 2 In chemically-induced writhing models BW443C, administered subcutaneously, demonstrated dose-related antinociceptive effects less potent than morphine and of a similar order to pethidine and D-propoxyphene. In assays using heat as t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
1

Year Published

1988
1988
2008
2008

Publication Types

Select...
4
2
2

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(10 citation statements)
references
References 25 publications
1
8
1
Order By: Relevance
“…Although probably a p-receptor agonist, the high doses of BW443C required to obtain antinociceptive effects in the tail-flick assay support recent findings that this opioid peptide is less potent where CNS penetration is required (Follenfant et al, 1988). U50488 also failed to increase latency in the tail-flick assay, supporting the notion that K-receptor agonists are relatively ineffective against thermallyinduced nociception (Tyers, 1980).…”
Section: Effects On Antinociceptive Modelssupporting
confidence: 69%
See 2 more Smart Citations
“…Although probably a p-receptor agonist, the high doses of BW443C required to obtain antinociceptive effects in the tail-flick assay support recent findings that this opioid peptide is less potent where CNS penetration is required (Follenfant et al, 1988). U50488 also failed to increase latency in the tail-flick assay, supporting the notion that K-receptor agonists are relatively ineffective against thermallyinduced nociception (Tyers, 1980).…”
Section: Effects On Antinociceptive Modelssupporting
confidence: 69%
“…However, the selective p-receptor agonist DAGOL (Kosterlitz & Paterson, 1981;Handa et al, 1981) exhibited a more prolonged hypotension and the time-course of this effect may have exceeded inhibition of reflex depressor responses. Similar problems were encountered in the quantitative evaluation of the opioid peptide BW443C, a postulated p-receptor agonist that displays peripherally-mediated antinociceptive effects (Follenfant et al, 1988). In contrast to U50488, dynorphin41-13) (1 mgkg'-i.v.…”
Section: Effects On Antinociceptive Modelsmentioning
confidence: 98%
See 1 more Smart Citation
“…This method has been used to demonstrate the contribution of eicosanoids, sympathetic amines, cAMP and cytokines to the development of peripheral inflammatory hyperalgesia (Ferreira & Nakamura, 1979a; Ferreira et al ., 1988; 1993; Francischi et al ., 1988; Cunha et al ., 1991; 1992; 1999), as well as the peripheral analgesic effect of opiates (Ferreira & Nakamura, 1979b) and NSAIDs (Ferreira et al ., 1988; Cunha et al ., 1991; 1992). These concepts and findings have been extensively confirmed with other methodologies such as formalin‐induced flinching (Vinegar et al ., 1976; Choi et al ., 2001; Granados‐Soto et al ., 2001), chemically induced writhing (Duarte et al ., 1988; Follenfant et al ., 1988; Ribeiro et al ., 2000b), the classical Randall‐Sellito method (Aley et al ., 1995) and others (Vinegar et al ., 1976; Safieh‐Garabedian et al ., 2002). Furthermore, this method is able to discriminate between peripheral and central analgesic effects of drugs (Ferreira et al ., 1978; Duarte & Ferreira, 1992).…”
Section: Methodsmentioning
confidence: 99%
“…Typically, the reaction time before treatment was 31.5 Ϯ 1 s (mean Ϯ SEM; n ϭ 5). This method has been used extensively in our previous studies over the years, where the results have been replicated by other laboratories and by us, using the same or other nociceptive behavioral tests (11,40,41). To choose the single dose used for the agonists, receptor antagonists, and enzyme inhibitors, these agents were previously tested in pilot dose-response studies performed before the experiments described.…”
Section: Mechanical Hypernociception Testmentioning
confidence: 99%